multiple myeloma

August 1, 2018

Machine-learning Algorithm Predicts Responses to Myeloma Treatments

News

Inserting data from genetically similar patients into a machine-learning algorithm may help predict which multiple myeloma patients will benefit from Velcade (bortezomib) or Revlimid (lenalidomide) treatment, a study shows. Those findings ... Read more

April 27, 2018

Phase 1 Trial for Investigational Therapy STRO-001 Treats First Myeloma, Lymphoma Patients

News

A Phase 1 clinical trial testing therapy candidate STRO-001 for lymphoma and myeloma has started treating its first patients, announced Sutro Biopharma, the therapy’s maker. The open-label, multicenter trial (NCT03424603) will ... Read more

March 9, 2018

Phase 1/2 Trial of Medigene’s MDG1011 Immunotherapy in Blood Cancer Patients Set to Begin

News

A Phase 1/2 clinical trial testing an experimental T-cell therapy for the first time in human patients will begin in the coming weeks after receiving approval from the German ... Read more

January 31, 2018January 31, 2018

Nanoparticle-targeted Phototherapy Tested in Mice; Might Be Multiple Myeloma Therapy Someday

News

Animal studies have shown that a new treatment strategy using phototherapy might be used to treat inaccessible cancers, including multiple myeloma. The therapy makes use of light-sensitive medicines that ... Read more

September 20, 2017September 20, 2017

Safety Concerns Lead to Partial Hold of 2 Tecentriq Trials in Myeloma, Lymphoma

News

Based on recently published safety data, two clinical trials evaluating combinations of Tecentriq (atezolizumab) in multiple myeloma and follicular lymphoma patients were placed on partial clinical hold at the request of the U.S. ... Read more

June 28, 2017June 28, 2017

Potential Use of Ninlaro as Maintenance Therapy in Multiple Myeloma Shown in Phase 1/2 Trials

News

Patients with newly diagnosed multiple myeloma benefit significantly from a combination of Ninlaro (ixazomib) plus Revlimid (lenalidomide) and dexamethasone, followed by Ninlaro maintenance therapy, according to long-term follow-up data ... Read more

June 13, 2017

Myeloma Patient Enrollment in 2 Keytruda Trials Suspended After Unexplained Deaths

News

Merck has suspended patient enrollment in two Phase 3 clinical trials, KEYNOTE-183 and KEYNOTE-185, testing Keytruda (pembrolizumab) in combination with other therapies in patients with multiple myeloma, due to unexplained ... Read more

June 7, 2017

New CAR T-cell Therapy Seen to Induce Lasting Remission in Advanced Multiple Myeloma Patients

News

An ongoing Phase 1 trial testing a novel CAR T-cell therapy has shown promising results in relapsed or treatment-resistant (refractory) multiple myeloma patients. The new anti-BCMA therapy, called LCAR-B38M, induced ... Read more

March 31, 2017March 31, 2017

Leukemia & Lymphoma Society and Black Church Initiative Join to Help African-Americans with Myeloma

News

The Leukemia & Lymphoma Society (LLS) and the National Black Church Initiative (NBCI) are closing March, Myeloma Awareness Month, with the start of a joint church-based initiative to raise awareness of the ... Read more

March 15, 2017March 15, 2017

Patient Power Backs Multiple Myeloma Patient’s Quest to Run 101st Marathon

News

Don Wright, who recently finished his 100th marathon while on active treatment for multiple myeloma, will continue running, but now with the support of the advocacy organization Patient Power. Wright, ... Read more